Johnson & Johnson (JNJ): A Bull Case Theory

We came across a bullish thesis on Johnson & Johnson on Max Dividends’s Substack. In this article, we will summarize the bulls’ thesis on JNJ. Johnson & Johnson's share was trading at $205.34 as of December 1st. JNJ’s trailing and forward P/E were 19.99 and 17.99 respectively according to Yahoo Finance. Photo by Ani Kolleshi on Unsplash Johnson & Johnson (J&J) is a global healthcare leader with three major divisions: pharmaceuticals, medical devices, and consumer health products. Pharmaceuticals remain ...